黄病毒
病毒学
寨卡病毒
登革热病毒
登革热
黄病毒科
抗病毒药物
黄热病
日本脑炎
生物
药物发现
病毒
脑炎
生物信息学
丙型肝炎病毒
作者
Yan Wang,Xuping Xie,Pei‐Yong Shi
标识
DOI:10.1016/j.antiviral.2022.105423
摘要
Infections with mosquito-borne flaviviruses, such as Dengue virus, ZIKV virus, and West Nile virus, pose significant threats to public health. Flaviviruses cause up to 400 million infections each year, leading to many forms of diseases, including fatal hemorrhage, encephalitis, congenital abnormalities, and deaths. Currently, there are no clinically approved antiviral drugs for the treatment of flavivirus infections. The non-structural protein NS4B is an emerging target for drug discovery due to its multiple roles in the flaviviral life cycle. In this review, we summarize the latest knowledge on the structure and function of flavivirus NS4B, as well as the progress on antiviral compounds that target NS4B.
科研通智能强力驱动
Strongly Powered by AbleSci AI